<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">global-journal-of-medical-research</journal-id>
<journal-title-group>
<journal-title>Global Journal of Medical Research</journal-title>
</journal-title-group>
<issn publication-format="print">0975-5888</issn>
<issn publication-format="electronic">2249-4618</issn>
<publisher><publisher-name>Global Journals Publishing Group Incorporated</publisher-name></publisher>
<self-uri xlink:href="https://globaljournals.org/journal-seo-export/jats/59685.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">59685</article-id>
<title-group>
<article-title>Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators</article-title>
<subtitle>Smoking Impact on COVID-19 Outcomes and Treatment</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Shah</surname><given-names>Naveed Nazir</given-names></name><xref ref-type="aff" rid="aff1" />
</contrib>
<contrib contrib-type="author"><name><surname>Dar</surname><given-names>Khurshid Ahmad</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Quibtiya</surname><given-names>Syed</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Datta</surname><given-names>Bikram Singh</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Farooq</surname><given-names>Syed Suriya</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Mushtaq</surname><given-names>Mehvish</given-names></name></contrib>
</contrib-group>
<aff id="aff1">INDIA</aff>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-05-20">
<day>20</day>
<month>05</month>
<year>2022</year>
</pub-date>
<volume>22</volume>
<issue>K2</issue>
<fpage>67</fpage>
<lpage>79</lpage>
<abstract><p>Abstract not found</p></abstract>
<kwd-group kwd-group-type="author-generated">
<kwd>COVID-19</kwd>
<kwd>smoking</kwd>
<kwd>mechanical ventilation</kwd>
<kwd>hazard analysis and mycobacterium indicus pranii (MIP).</kwd>
</kwd-group>
<self-uri content-type="pdf" xlink:href="https://globaljournals.org/GJMR_Volume22/6-Evaluation-of-Surrogate-Risk-Factors.pdf" />
<self-uri content-type="html" xlink:href="https://globaljournals.org/scholarly-articles/evaluation-of-surrogate-risk-factors-for-severe-progression-of-covid-19-in-tobacco-smoking-sub-population-and-its-possible-amelioration-by-immune-modulators/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>Objectives: With emergence of SARS-CoV-2 some researcher have identified Smoking as risk factor for severe outcome of COVID-19 while as other have proposed beneficial role of tobacco based products against as they retards severe progression of disease in smoker subpopulation. The major drawbacks of these studies were as majority of these studies were conducted in small cohort so conclusive evidences are lacking. Study design: This original research paper is based on population based cohort study.</p>
</sec>
</body>
</article>